RET-IN-10
Code | Size | Price |
---|
TAR-T63782-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T63782-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T63782-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
RET-IN-10 is a potent inhibitor of RET, in which RET loss-of-function mutations cause congenital megacolon and its gain-of-function mutations are associated with a variety of human tumors. RET-IN-10 has shown research potential for cancer diseases (information from patent WO2021135938A1, compound 18).
CAS:
2662622-44-6
Molecular Weight:
536.66
Purity:
0.98
SMILES:
Cn1cc(cn1)-c1cc(-c2ccc(nc2)N2CCC(CC2)N=S(C)(=O)c2ccccc2)c2c(cnn2c1)C#N